Is innervation an early target in autoimmune diabetes?
- 30 November 2003
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 24 (11) , 574-579
- https://doi.org/10.1016/j.it.2003.09.010
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Beta cell MHC class I is a late requirement for diabetesProceedings of the National Academy of Sciences, 2003
- Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusiveNature Medicine, 2003
- Islet abnormalities in the pathogenesis of autoimmune diabetesTrends in Endocrinology & Metabolism, 2002
- Pancreatic organogenesis — developmental mechanisms and implications for therapyNature Reviews Genetics, 2002
- Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod MiceThe Journal of Experimental Medicine, 2001
- T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in MiceThe Journal of Immunology, 2001
- Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune EncephalitisThe Journal of Immunology, 2001
- Expression of Neuronal Traits in Pancreatic Beta CellsPublished by Elsevier ,1997
- GAD, diabetes, and Stiff-Man syndrome: Some progress and more questionsJournal of Endocrinological Investigation, 1994
- New perspectives on the microvasculature of the islets of Langerhans in the ratDiabetes, 1982